Screener
Moderna MRNA United States — Property, plant and equipment, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.
The source filing: Moderna’s 10-K, filed February 20, 2026.
- Filed
- Feb 20, 2026, 4:02 PM EST
- Fiscal year
- FY2025
- Accession
- 0001682852-26-000033
FAQ
- What is Moderna's united states — property, plant and equipment, net?
- Moderna (MRNA) reported united states — property, plant and equipment, net of $1.47B in Q4 2025.
- How has Moderna's united states — property, plant and equipment, net changed year-over-year?
- Moderna's united states — property, plant and equipment, net decreased by 4.2% year-over-year, from $1.53B to $1.47B.
- What does united states — property, plant and equipment, net mean?
- This metric represents the net book value of tangible long-term assets located within the United States, including manufacturing facilities, laboratories, and specialized equipment. It serves as a proxy for the company's domestic infrastructure investment and its capacity to scale production for clinical and commercial supply. Tracking this value helps investors assess the capital intensity required to support the firm's research and development pipeline.
Ask your AI about Moderna's united states — property, plant and equipment, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude